Bottom line
SPXV vs FSPHX: the short answer
SPXV (ProShares S&P 500 Ex-Health Care ETF) and FSPHX (Health Care Portfolio) are both etfs.
But SPXV is far broader, holding 449 positions to 152 for FSPHX, so beyond the top names it adds exposure FSPHX doesn't have.
SPXV is cheaper at 0.09% vs 0.62% — a difference of $53 a year per $10,000 invested.
Over five years, SPXV returned +15.1% a year vs +4.0% for FSPHX (reporting dates differ).
Updated Nov 19, 2026
SPXV vs FSPHX side by side
| SPXV | FSPHX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | ProShares | Fidelity |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.09% | 0.62% |
| Annual cost per $10k | $9 | $62 |
| 10-yr cost on $10k (prospectus) | $162 | $774 |
| Max front load | None | — |
| 12b-1 fee | — | 0% |
| 1-yr return | +18.1% | +14.4% |
| 5-yr return (annualized) | +15.1% | +4.0% |
| 10-yr return (annualized) | — | +9.0% |
| Best quarter | +21.7% | +22.2% |
| Worst quarter | −20.7% | −15.0% |
| Net assets (fund) | $40.2M | $5.8B |
| Number of holdings | 449 | 152 |
| Portfolio turnover | 4% | 69% |
| Returns as of | Dec 31, 2025 | Apr 30, 2026 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SPXV | FSPHX | Difference |
|---|---|---|---|
| 2025 | +18.1% | +14.4% | +3.7% |
| 2024 | +28.0% | +4.9% | +23.1% |
| 2023 | +30.7% | +4.1% | +26.6% |
| 2022 | −20.6% | −12.8% | −7.7% |
| 2021 | +28.7% | +11.5% | +17.2% |
| 2020 | +18.9% | +24.4% | −5.5% |
| 2019 | +33.0% | +31.5% | +1.5% |
| 2018 | −6.4% | +7.4% | −13.8% |
| 2017 | +21.4% | +24.0% | −2.6% |
| 2016 | +14.2% | −10.7% | +24.9% |
Source: Fund prospectus bar charts
Holdings overlap
SPXV and FSPHX share none of their top holdings.
SPXV top 10
- NVIDIA Corp. — 8.60%
- Apple, Inc. — 7.68%
- Microsoft Corp. — 5.60%
- Amazon.com, Inc. — 4.43%
- Alphabet, Inc. — 3.71%
- Broadcom, Inc. — 3.55%
- Alphabet, Inc. — 2.95%
- Meta Platforms, Inc. — 2.32%
- Tesla, Inc. — 2.05%
- Micron Technology, Inc. — 1.83%
FSPHX top 10
- ELI LILLY and CO — 8.03%
- Danaher Corp — 6.89%
- JOHNSON and JOHNSON — 4.91%
- Thermo Fisher Scientific Inc — 4.33%
- Unitedhealth Group Inc — 3.49%
- Alnylam Pharmaceuticals Inc — 2.40%
- Gilead Sciences Inc — 2.21%
- Boston Scientific Corp — 2.17%
- Ascendis Pharma A/s — 2.17%
- Fidelity Revere Street Trust — 2.17%
FAQ
What is the difference between SPXV and FSPHX?
Which is cheaper, SPXV or FSPHX?
Should I own both SPXV and FSPHX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.